
E.A. Weeks
Elizabeth-Ann "EA" Weeks, J.D., Ph.D. is a life sciences deal lawyer, registered patent attorney, and Counsel at Troutman Pepper Locke in Atlanta.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
Sep 24, 2026
Structuring CGT Deals for the Long Term with Troutman Pepper Locke's EA Weeks, J.D., Ph.D.
9:52
9:57
10:05
10:16
10:29

E.A. WeeksGUEST
Yeah, it's a great, [chuckles] it's a great question, and it's a critical point in, in these deals.

E.A. WeeksGUEST
Um, when I started my career, you know, I guess almost 20 years ago now, um, small molecules were still the, the thing.

E.A. WeeksGUEST
And, um, you know, in terms of synthesis and manufacturing and scale-up, right, they're-- it's fairly straightforward, right? With, with known kind of synthetic methods and processes.

E.A. WeeksGUEST
Um, but in CGT products, right, that, that's m- completely different, right? And manufacturing is not merely an operational issue in these deals.

E.A. WeeksGUEST
It is a central business and legal issue, um, and it sits at the heart of every negotiation that we do here.
6 MINS LATER
E
16:20Erin HarrisHOST
So, you know, like I said, what are the deal terms that really tend to surprise people?